A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024

Geographical, racial/ethnic differences seen for triple-negative breast cancer

by Lori SolomonThere are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online Mar

Updated on: January 03,2024

Geographical, racial/ethnic differences seen for triple-negative breast cancer

by Lori SolomonThere are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online Mar

Updated on:January 03,2024

Researchers block metastasis-promoting enzyme, halt spread of breast cancer

by University of California, San FranciscoCredit: CC0 Public DomainIn a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists hav

Updated on: June 01,2024

Researchers block metastasis-promoting enzyme, halt spread of breast cancer

by University of California, San FranciscoCredit: CC0 Public DomainIn a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists hav

Updated on:June 01,2024

New inflammatory biomarker predicts elevated thrombosis risk in cancer patients

by Medical University of ViennaCredit: Wikimedia CommonsCancer patients are known to have an increased risk of thrombosis. As part of the CATS study, MedUni Vienna researchers have now investigat

Updated on: March 12,2024

New inflammatory biomarker predicts elevated thrombosis risk in cancer patients

by Medical University of ViennaCredit: Wikimedia CommonsCancer patients are known to have an increased risk of thrombosis. As part of the CATS study, MedUni Vienna researchers have now investigat

Updated on:March 12,2024

New study discovers pre-treatment cognitive impairment in younger cancer patients

byUniversity of California, IrvineCredit: Unsplash/CC0 Public DomainA team of researchers led by the University of California, Irvine has discovered that adolescent and young adult cancer

Updated on: January 15,2024

New study discovers pre-treatment cognitive impairment in younger cancer patients

byUniversity of California, IrvineCredit: Unsplash/CC0 Public DomainA team of researchers led by the University of California, Irvine has discovered that adolescent and young adult cancer

Updated on:January 15,2024

Researchers map DNA damage links to onset of skin cancer, melanoma

by Washington State UniversityDNA damage resulting in multiple broken chromosomes. Credit: Wikipedia/CC BY-SA 3.0A critical link in mapping recurrent mutations of melanoma—the most serious form o

Updated on: March 12,2024

Researchers map DNA damage links to onset of skin cancer, melanoma

by Washington State UniversityDNA damage resulting in multiple broken chromosomes. Credit: Wikipedia/CC BY-SA 3.0A critical link in mapping recurrent mutations of melanoma—the most serious form o

Updated on:March 12,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on: May 27,2024

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on:May 27,2024

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Updated on: January 02,2024

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Updated on:January 02,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on: January 30,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on:January 30,2024

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on: January 08,2024

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on:January 08,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on: March 09,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on:March 09,2024